Trial of pasireotideLAR and Topotecan in Relapsed or Refractory Small Cell Lung Cancer

This study is currently recruiting participants.
Verified July 2011 by South Florida Veterans Affairs Foundation for Research and Education
Sponsor:
Collaborator:
Novartis Pharmaceuticals
Information provided by:
South Florida Veterans Affairs Foundation for Research and Education
ClinicalTrials.gov Identifier:
NCT01417806
First received: August 15, 2011
Last updated: NA
Last verified: July 2011
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)